Clinical prognostic variables in young patients (under 40 years) with hepatitis B virus‐associated hepatocellular carcinoma

Abstract

Current guidelines for HCC screening in patients with HBV may lead to a delay in diagnosis in non-cirrhotic patients under 40 years. Consideration should be given to modifying current recommendations to advocate entering HBV patients into a cancer-screening program at young age.